'Lipid lowering' diaporamas de présentation

Drugs for hyperlipidemia

Drugs for hyperlipidemia. Prof. Yieldez Bassiouni. ILOs. By the end of those 2 lectures the student will be able to: Define hyperlipidemia vs normal lipid levels Discuss the non-pharmacological treatment of hyperlipidemia

776 views • 57 slides

Drugs for hyperlipidemia

Drugs for hyperlipidemia. Prof. Yieldez Bassiouni. ILOs. By the end of those 2 lectures the student will be able to: Define hyperlipidemia vs normal lipid levels Discuss the non-pharmacological treatment of hyperlipidemia

709 views • 55 slides

Clinical aspects of managing the cardiovascular risk in diabetes Dr SH Song MD FRCP

Clinical aspects of managing the cardiovascular risk in diabetes Dr SH Song MD FRCP Consultant Diabetologist Northern General Hospital Sheffield. Increased CHD in type 1 diabetes. Laing at al Diabetologia 2003; 46: 760-5. STENO-2 Evidence - Intensive multifactorial intervention are

675 views • 53 slides

Closing the CHD Treatment GAP

Closing the CHD Treatment GAP. Saving Lives Through Better Implementation of Secondary Prevention Measures. The Impact of Coronary Heart Disease in the United States. 14 million Americans alive today have a history of myocardial infarction, angina, or both. 1

740 views • 47 slides

Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone

ALLHAT. Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone. Preliminary Results from ALLHAT. The ALLHAT Collaborative Research Group. ALLHAT. Study Leadership - 1. Steering Committee chairs:

536 views • 46 slides

Pharmaceutical Industry Update: Challenges, Opportunities, & Outlook

Pharmaceutical Industry Update: Challenges, Opportunities, & Outlook. Bin Li, Ph.D., MBA Equity Research Analyst Global Pharmaceuticals Merrill Lynch. Disclaimer. Introduction. Current Industry Overview Issues & Challenges Positives & Catalysts Therapeutic Analysis

880 views • 42 slides

HEART ATTACK

?. ?. AMI. HEART ATTACK. DRUGS IN HYPERLIPIDEMIA. DRUGS IN HYPERLIPIDEMIA. ILOs. By the end of those 2 lectures [23 slides for studing ] you will be able to:. Define hyperlipidemia vs normal lipid levels

559 views • 41 slides

HEART ATTACK

?. ?. AMI. HEART ATTACK. DRUGS IN HYPERLIPIDEMIA. DRUGS IN HYPERLIPIDEMIA. ILOs. By the end of those 2 lectures [23 slides for studing ] you will be able to:. Define hyperlipidemia vs normal lipid levels

533 views • 40 slides

589 views • 38 slides

NHS Surrey Lipid Guidelines

567 views • 36 slides

The Anglo-Scandinavian Cardiac Outcomes Trial

563 views • 30 slides

The Anglo-Scandinavian Cardiac Outcomes Trial

418 views • 30 slides

Rationale

358 views • 26 slides

List of Top Best Pcd Pharma Franchise Companies in Ahmedabad, Gujarat by TradeMaantra.com

Looking for the best franchise Pcd pharma companies in Ahmedabad, Gujarat (India)? TradeMaantra can provide you a list of top 20 verified Pcd pharma franchise companies in Ahmedabad. The pharma startups can contact to the best suitable pharma franchise company and also they can apply for pharma Pcd franchise in Ahmedabad region of India. Get engaged with Trademaantra.com, Grow your pharmaceutical business more and more.

88 views • 8 slides

Risk for all vascular events across HDL-c quartiles, with or without lipid-lowering therapy

Risk for all vascular events across HDL-c quartiles, with or without lipid-lowering therapy. No lipid-lowering medication. 2. Lipid-lowering medication. 1. HR. 0,5. 1. 2. 3. 4. Van de Woestijne et al ., JACC 2013.

117 views • 2 slides